Drug intelligence / Profile preview

Jinghua Jiedu decoction

Development stage: Unknown
Lead developer: First Affiliated Hospital of Henan University of Chinese Medicine
Administration: Oral

Overview

Jinghua Jiedu decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of COVID-19. It is primarily being investigated for its efficacy in treating asymptomatic and mild cases of the disease. As a decoction, it follows the TCM therapeutic principle of 'clearing heat and detoxifying' (Jiedu) to manage viral infections. The formula is currently under clinical evaluation in trials sponsored by The First Affiliated Hospital to Henan University of Chinese Medicine, where it is being compared against standard care or other TCM interventions to assess its impact on viral clearance and symptom resolution.

Brand names: 荆花解毒合剂
Other names: Jinghua Jiedu DecoctionJinghua Jiedu formulaJinghua Jiedu Tang

Beyond the preview

Go deeper on Jinghua Jiedu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinghua Jiedu decoction.

Explore the full profile